Isomorphic Labs in Advanced Talks for $2 Billion-Plus Funding Led by Thrive
Isomorphic Labs, an AI-powered drug discovery company spun out of Google DeepMind, is in advanced discussions to raise more than $2 billion in a new funding round, according to people familiar with the plan. Thrive Capital is set to lead the financing, with Alphabet expected to participate.
The company was spun out of DeepMind in 2021 to commercialize AI drug discovery built around AlphaFold. Isomorphic raised $600 million in its first external round last year, also led by Thrive, and the new capital is expected to support its drug design engine and global expansion. It already has partnerships with Johnson & Johnson, Eli Lilly and Novartis.
From the sources (6 posts)
@financialjuiceGoogle's Isomorphic labs to raise $2 bln in new funding. $GOOGL
@businessIsomorphic Labs, an AI-powered drug discovery company spun out of Google DeepMind, is in advanced discussions to raise more than $2 billion in a new round of funding, according to people familiar with the plan.
@andrewcurran_Sir Demis's biolab is raising $2 billion.
@wallstengineGOOGLE’S AI DRUG DISCOVERY SPINOUT IS RAISING OVER $2B Bloomberg reports Isomorphic Labs is in advanced talks to raise more than $2B in new funding. The company spun out of Google DeepMind in 2021 to commercialize AI drug discovery built
@techmemeSources: Isomorphic Labs, an AI-powered drug discovery company spun out of Google DeepMind, is in advanced talks to raise $2B+ led by Thrive Capital (Bloomberg) (Visit Techmeme dot com for the link and full context!)
@mtsliveSITUATION BREWING: Isomorphic Labs, the AI drug discovery company spun out of Google DeepMind, is in advanced discussions to raise more than $2 billion led by Thrive Capital.